medicina61巻6号

2024年05月発行

特集 睡眠にまつわる疑問にすべて答えます！—あなたの患者の睡眠中に何かが起きているかもしれない 睡眠に関する総論

睡眠薬の種類と治療戦略—不眠に対する薬物治療の限界を念頭に置く

著者： 三原丈直¹²

所属機関： ¹関西電力病院睡眠関連疾患センター ²関西電力医学研究所睡眠医学研究部

ページ範囲：P.836 - P.840

Point
◎睡眠薬の種類については睡眠と覚醒のしくみで理解する．
◎不眠に対する薬物治療はそれのみで完結するものではなく，不眠治療の全体のなかで考える．

参考文献

1）Current concepts in therapy. Sedative-hypnotic drugs. Ⅱ. Chloral hydrate. N Engl J Med 255：706, 1956 PMID 13369697

2）Cozanitis DA：One hundred years of barbiturates and their saint. J R Soc Med 97：594-598, 2004 PMID 15574863

3）Sternbach LH：The benzodiazepine story. J Med Chem 22：1-7, 1979 PMID 34039

4）Wick JY：The history of benzodiazepines. Consult Pharm 28：538-548, 2013 PMID 24007886

5）Saper CB, et al：Sleep state switching. Neuron 68：1023-1042, 2010 PMID 21172606

6）Rye DB, Wisden W：GABA its metabolism, receptors, and the drugs for treating insomnias and hypersomnias. Kryger M, et al（ed）：Principle and Practice of Sleep Medicine 7th ed, pp 472-482, Elsevier, Amsterdam, 2022

7）Equihua AC, et al：Orexin receptor antagonists as therapeutic agents for insomnia. Front Pharmacol 4：163, 2013 PMID 24416019

8）Schmidt C, et al：A time to think；Circadian rhythms in human cognition. Cogn Neuropsychol 24：755-789, 2007 PMID 18066734

9）河合　真（著），香坂　俊（監）：極論で語る睡眠医学，pp 121-140，丸善出版，2016

10）Möhler H, et al：A new benzodiazepine pharmacology. J Pharmacol Exp Ther 300：2-8, 2002 PMID 11752090

11）Lu J, Greco MA：Sleep circuitry and the hypnotic mechanism of GABAa drugs. J Clin Sleep Med 2：S19-S26, 2006 PMID 17557503

receptor subtypes. Nat Rev Drug Discov 10：685-697, 2011 PMID 21799515

13）Fluyau D, et al：Challenges of the pharmacological management of benzodiazepine withdrawal, dependence, and discontinuation Ther Adv Psychopharmacol 8：147-168, 2018 PMID 29713452

14）Schmitz A：Benzodiazepine use, misuse, and abuse；A review. Ment Health Clin 6：120-126, 2016 PMID 29955458

15）Rihel J, Schier AF：Sites of action of sleep and wake drugs；Insights from model organisms. Curr Opin Neurobiol 23：831-840, 2013 PMID 23706898

16）Uygun DS, et al：Bottom-up versus top-down induction of sleep by zolpidem acting on histaminergic and neocortex neurons. J Neurosci 36：11171-11184, 2016 PMID 27807161

17）Riemann D, et al：The European Insomnia Guideline；An update on the diagnosis and treatment of insomnia 2023. J Sleep Res 32：e14035, 2023 PMID 38016484

18）Mason R, Brooks A：The electrophysiological effects of melatonin and a putative melatonin antagonist（N-acetyltryptamine）on rat suprachiasmatic neurones in vitro. Neurosci Lett 95：296-301, 1988 PMID 3226615

19）Burgess HJ, et al：Human phase response curves to three days of daily melatonin；0.5 mg versus 3.0 mg. J Clin Endocrinol Metab 95：3325-3331, 2010 PMID 20410229

20）Zammit G, et al：Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia. J Clin Sleep Med 3：495-504, 2007 PMID 17803013

21）Richardson GS, et al：Safety and subjective sleep effects of ramelteon administration in adults and older adults with chronic primary insomnia；A 1-year, open-label study. J Clin Psychiatry 70：467-476, 2009 PMID 19284927

22）Sateia MJ, et al：Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults；An American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med 13：307-349, 2017 PMID 27998379

23）Sakurai T：The neural circuit of orexin（hypocretin）；Maintaining sleep and wakefulness. Nat Rev Neurosci 8：171-181, 2007 PMID 17299454

24）De Crescenzo F, et al：Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults；A systematic review and network meta-analysis. Lancet 400：170-184, 2022 PMID 35843245

25）Spielman AJ, et al：A behavioral perspective on insomnia treatment. Psychiatr Clin North Am 10：541-553, 1987 PMID 3332317